Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification. (2012)

First Author: Hamasaki M
Attributed to:  The Wales Institute of Social and Economic Research, Data and Methods (WISERD) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/stem.1221

PubMed Identifier: 22949078

Publication URI: http://europepmc.org/abstract/MED/22949078

Type: Journal Article/Review

Volume: 30

Parent Publication: Stem cells (Dayton, Ohio)

Issue: 11

ISSN: 1066-5099